Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

Do we know the severity of UP for each patient? I haven’t seen that revealed other than inclusion criteria that stated there was a global assessment involved. The b cohort could have enrolled a higher number of severe cases over all than the first and last. Also note that on the poster there is one outlier in results for each group, where a and c’s outlier had shorter time retention, while b had one outlier at >4 hours. All that can easily be explained by UP severity and accompanying damage or weakness to the colon with cohort b assigned a higher number of those patients.